NIH UPDATE

On December 21, 2005, the Senate approved by voice vote the FY 2006 Labor-HHS-Education Appropriations bill that included a less than 1% increase of $253 million for the NIH -- a funding increase that falls below the medical inflation index.  The same bill had already passed the house a week earlier by a vote of 215-213.   In addition, the House and Senate both passed a  FY 2006 defense spending bill (H.R. 2863) that included a 1 percent across-the-board cut for all discretionary programs (except for Department of Veterans Affairs programs).

These two measures combined now mean that NIH funding will be cut for the first time in 35 years.  As we noted in a policy alert (click here) sent out electronically in late November of 2005, funding cuts at NIH will likely lead to delays and setbacks in high priority programs that hold tremendous hope for developing better tools for the prevention, detection, and treatment of cancer. 

By all indications, the 2006 budget and appropriations climate will be even more challenging as the NIH will likely be facing cuts of even greater magnitude.  Advocates across the country who care about the urgent need for continued scientific progress in cancer research must be more proactive in 2006 and beyond about voicing our support for the strongest possible federal funding for biomedical research. 

Earlier in the year, the Senate had passed a version of the Labor-HHS appropriations bill that called for a 3.7% increase of roughly $1 billion for the NIH.  However, the version passed by the House and supported by the President only allowed for about a 1% increase.  When the bill went into conference, the House’s NIH figure prevailed. 

But, when the Labor-HHS appropriations bill was reported out of conference and came back up for a vote in the House on November 17th, it was defeated by a vote of 209-222. Instead of bringing the Labor-HHS spending bill to the Senate floor, the Senate passed a motion introduced by Senator Durbin (D-IL) that instructed the bill’s conferees to restore the Senate’s original NIH increase of around $1 billion or 3.7%.  The leadership in the House agreed to return to conference on the Labor-HHS spending bill (HR 3010) and the conferees were able to achieve some minor modifications that allowed for passage in both the House and Senate without changing the less than 1% increase for NIH funding. 

 

 

 

 

 

     
     
 
 
Friends of Cancer Research is a 501c(3) non-profit organization; all contributions are tax-deductible.